HYDROXYPROGESTERONE CAPROATE J Code: J1729

Drug & Product Overview

HCPCS Descriptor Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg

HCPCS Added Date January 1, 2018

Manufacturer Slayback Pharma

Generic Status Multi-Source; Generic

About HYDROXYPROGESTERONE CAPROATE

Hydroxyprogesterone Caproate is a medication aligned to the HCPCS J Code: J1729 for billing, pricing, and reimbursement purposes in the United States. It is a Women's Health drug manufactured by Slayback Pharma.

Manufacturers, reach out to us to add more information.

NDC Code Information

2 NDC packages are crosswalked to J1729. Package detail is available to logged-in subscribers.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
•••••-••••-•• Log in to view	HYDROXYPROGESTERONE CAPROATE
	HYDROXYPROGESTERONE CAPROATE

Login to view 2 NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

HYDROXYPROGESTERONE CAPROATE CPT Administration Codes

CPT Code	Description
96401	Chemotherapy administration, subcutaneous or intramuscular; non-hormonal anti-neoplastic

Not on the CMS JW / JZ list

CMS does not include Hydroxyprogesterone Caproate (J1729) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J1729. Wastage billing guide →

HYDROXYPROGESTERONE CAPROATE Medically Unlikely Edits (MUE)

The most billing units of J1729 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 10 mg.

Practitioner Office & Hospital Outpatient

25 units / day

= 250 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

HYDROXYPROGESTERONE CAPROATE Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Advanced adenocarcinoma of the uterine corpus (Stage III–IV) Amenorrhea (primary or secondary) Abnormal uterine bleeding due to hormonal imbalance (no organic pathology)

Frequently Asked Questions

Is there an available Hydroxyprogesterone Caproate billing and coding guide?

We have not yet identified a manufacturer source of Hydroxyprogesterone Caproate billing and coding information.

Are there any available Hydroxyprogesterone Caproate patient assistance programs?

Our team did not identify a source for Hydroxyprogesterone Caproate patient assistance information. Please reach out to our team if you feel that this is a mistake.

Where can I find Hydroxyprogesterone Caproate prescribing information?

HYDROXYPROGESTERONE CAPROATE prescribing information can be found at the link below: Visit Here →

Where can I find Hydroxyprogesterone Caproate side effect information?

Our team has not yet identified a source of side effects information for HYDROXYPROGESTERONE CAPROATE. Please check back in a few weeks.

Does billing HYDROXYPROGESTERONE CAPROATE require JZ/JW wastage modifiers?

CMS does not include HYDROXYPROGESTERONE CAPROATE (J1729) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J1729. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.